One of these stocks has significantly outperformed the other over the past year. Will that continue?

3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

02:23pm, Tuesday, 04'th Oct 2022 The Motley Fool
These biotech stocks are finding game-changing therapies, and their shares are up as a result.
"Those that fail to learn from history are doomed to repeat it.” -Winston Churchill

Is Eli Lilly Stock a Buy Following This Competitor's Major Win?

02:37pm, Monday, 03'rd Oct 2022 The Motley Fool
Eli Lilly's recent jump could be short-lived.

Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?

01:35pm, Monday, 03'rd Oct 2022 Zacks Investment Research
AbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new indications. They are expected to drive revenues once Humira loses U.S. exclusivity in 2023.

Can Biogen (BIIB) Navigate Multiple Challenges & Grow Again?

01:15pm, Monday, 03'rd Oct 2022 Zacks Investment Research
Most of Biogen's (BIIB) key drugs are facing declining sales. Despite these challenges, we are hopeful that potential new product launches such as lecanemab, zuranolone and additional biosimilars can
2022's boost wasn't everything it was advertised to be for most seniors.

Why the Porsche IPO Generated So Much Excitement

01:47pm, Saturday, 01'st Oct 2022 The Motley Fool
Plus we look at some good news for Biogen and mortgage rate news.

Wall Street Breakfast: What Moved Markets

11:33am, Saturday, 01'st Oct 2022 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. The major U.S.
Here are seven major companies whose stocks moved on the week's news.

Why Biogen Stock Popped as Much as 37.1% This Week

05:23pm, Friday, 30'th Sep 2022 The Motley Fool
The company's Alzheimer's drug is showing promise in clinical trials.
Yahoo Finance Live's Seana Smith looks at several stocks trending in the after-hours trading session.
The company's Alzheimer's drug is showing promise in clinical trials.
Constellation Energy was the best performer in the Nasdaq 100 for the third quarter. Okta was the worst.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE